STOCK MARKET

Suraksha Diagnostic IPO Allotment: GMP At 0.45%, A Step-By-Step Guide To Check Allotment Status Online

Unlisted shares of Suraksha Diagnostic Ltd are currently trading at Rs 443 per share in the grey market, which is Rs 2 or 0.45 per cent higher than the IPO issue price, thus indicating a subdued listing.

Suraksha Diagnostic IPO GMP, Allotment Status, Listing Date: The Suraksha Diagnostic IPO allotment is scheduled to be finalised today, Wednesday. If allotted, investors will receive bank debit messages in the evening. They can also check the IPO allotment status online on the websites of BSE and NSE, as well as on registrar Kfin Technologies’ portal. Its GMP, which remained low since November 26, has now marginally inched up to 0.45 per cent, which indicates a subdued listing on December 6.

Read More: Suraksha Diagnostics IPO fully subscribed on Day 3: QIBs save the day, retail subscription at 0.75x

The initial public offering of Suraksha Diagnostic Ltd, which was opened on between November 29 and December 3, received an overall 1.27 times subscription. The retail category recieved a 0.94 times subscription in total, the NII (non-institutional investors) portion got 1.4 times subscription. Its QIB (qualified institutional buyer) category has been subscribed by 1.74 times.

The shares of Suraksha Diagnostic are scheduled to be listed on both BSE and NSE on December 6, Friday.

The allotment status can be checked online on the websites of BSE and NSE, as well as on the portal of the registrar Kfin Technologies Ltd.

Suraksha Diagnostic IPO GMP Today

According to market observers, unlisted shares of Suraksha Diagnostic Ltd are currently trading at Rs 443 per share in the grey market, which is Rs 2 or 0.45 per cent higher than the IPO issue price of Rs 441. It indicates a flat or discount listing on Friday.

The 0.45% GMP is marginally higher than the nil premium recorded till Monday.

The GMP is based on market sentiments and keeps changing. ‘Grey market premium’ indicates investors’ readiness to pay more than the issue price.

Read More: Emerald Tyre Manufacturers IPO to open on December 5; issue price band set at ₹90-95 apiece; check GMP, other details

Suraksha Diagnostic IPO: How To Check Allotment Status Online?

The IPO allotment status can be checked online by following these steps:

1) Go to the official BSE website via the URL —https://www.bseindia.com/investors/appli_check.aspx.

2) Under ‘Issue Type’, select ‘Equity’.

3) Under ‘Issue Name’, select ‘Suraksha Diagnostic Ltd’ in the dropbox.

4) Enter your application number, or the Permanent Account Number (PAN).

5) Then, click on the ‘I am not a robot’ to verify yourself and hit ‘Search’ option.

Your share application status will appear on your screen.

You can also visit direct Kfin Technologies Ltd’s portal — https://ipostatus.kfintech.com/ and check the Suraksha Diagnostic IPO allotment status.

Read More: Stocks To Watch: Vodafone Idea, Swiggy, Godrej Properties, IndiGo, Reliance Power, Honasa Consumer, PB Fintech

Suraksha Diagnostic IPO: More Details

Suraksha Diagnostic is a Kolkata-based integrated diagnostic chain. Its IPO consists of an offer for sale (OFS) of 19,189,330 equity shares worth Rs 846.25 crore, at the upper end of the price band, by promoters and investor shareholders, with no fresh issue component.

As the issue is completely an OFS, the company will not receive any proceeds and all the funds will go to the selling shareholders.

The company mobilised Rs 254 crore from anchor investors, ahead of the IPO.

The price band of the IPO was fixed at a price range of Rs 420-441 apiece.

Suraksha Diagnostic offers a one-stop integrated solution for pathology and radiology testing and medical consultation services to its customers through its extensive operational network, consisting of a flagship central reference laboratory, eight satellite laboratories and 194 customer touchpoints which include 48 diagnostic centres, and 146 sample collection centres (primarily franchised), across West Bengal, Bihar, Assam, and Meghalaya as of March 31, 2024.

ICICI Securities Ltd, Nuvama Wealth Management Ltd, and SBI Capital Markets Ltd are the book-running lead managers to the issue.

Source :
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top